Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Pain is a vital sign that depends on personal experience involving different factors such as
previous sensory and emotional experience, age, spiritual and cultural aspects, that makes it
harder to evaluate, especially in young children. Pain control is important to diminish the
anxiety of the child and family, also this is more important in patients who require
procedure and treatment that are more painful, like oncological and hematological patients.
The study aims to measure if the intranasal drugs (dexmedetomidine and fentanyl) has the same
outcomes when compared with intravenous drug (ketamine and midazolam), but with less side
effects. The participants are patients from an oncologic outpatient, that will be submitted
to cerebrospinal fluid puncture, myelogram or both will be randomized assigned to both
groups. The study will compare physiological variables ( heart rate, respiratory rate and
blood pressure) and sedation and pain scales to see if its work properly. The study purpose
is to evaluate if intranasal drug works in the same way with less side effects comparing with
the usual treatment.